Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

La Jolla Pharma focuses on regenerative medicine following acquisition of GliaMed's RILs

April 11, 2011

Zacharon and Pfizer join to develop drugs for orphan diseases

April 8, 2011

Medicago enters research collaboration for noninfluenza vaccine candidate

April 8, 2011

Bradmer Pharma ends Neuradiab license agreement for glioblastoma multiforme

April 8, 2011

DSP and BBI sign option license agreement for anticancer drug

April 8, 2011

OBT to use BioWa's Potelligent technology for cancer programs

April 8, 2011

Novartis to sell global rights for Elidel to Meda

April 8, 2011

Optimer and Cubist Pharma to copromote Dificid for Clostridium difficile infection

April 8, 2011

PRISM and Eisai collaborate on PRI-724

April 8, 2011

Millenium Pharma and Sunesis Pharma enter agreement for kinase inhibitors in oncology

April 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...